ClinicalTrials.gov record
Recruiting Phase 3 Interventional

OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity

ClinicalTrials.gov ID: NCT07140783

Public ClinicalTrials.gov record NCT07140783. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 1:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-MASKED STUDY OF THE SAFETY AND EFFICACY OF POS (0.75% PHENTOLAMINE OPHTHALMIC SOLUTION) IN PARTICIPANTS WITH PREVIOUS KERATOREFRACTIVE SURGERY WITH DECREASED VISUAL ACUITY UNDER MESOPIC CONDITIONS

Study identification

NCT ID
NCT07140783
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ocuphire Pharma, Inc.
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

  • 0.75% Phentolamine Ophthalmic Solution Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 1, 2025
Primary completion
Feb 28, 2026
Completion
Feb 28, 2026
Last update posted
Sep 30, 2025

2025 – 2026

United States locations

U.S. sites
23
U.S. states
10
U.S. cities
21
Facility City State ZIP Site status
Arizona Eye Care Chandler Arizona 85224 Recruiting
Carrot Eye Center Mesa Arizona 85202 Recruiting
Eye Doctors of Arizona Phoenix Arizona 85028 Recruiting
MRB Eye Care Consultants Scottsdale Arizona 85254 Recruiting
Global Research Management Glendale California 91204 Recruiting
Gordon Schanzlin New Vision La Jolla California 92037 Recruiting
Eye Research Foundation Newport Beach California 92663 Recruiting
California Eye Specialists Medical Group Pasadena California 91107 Recruiting
NVISION Clinical Research San Diego California 92117 Recruiting
Scripps Poway Eyecare and Optometry San Diego California 92130 Recruiting
Wolsten and Goldberg Eye Assoc. Torrance California 90505 Recruiting
Glaucoma Specialist of South Florida Delray Beach Florida 33484 Recruiting
Segal Drug Trials Delray Beach Florida 33484 Recruiting
Wyse Eyecare Northbrook Illinois 60062 Recruiting
Virdi Eye Clinic Rock Island Illinois 61201 Recruiting
Durrie Vision Overland Park Kansas 66210 Recruiting
Kannarr Eye Care Pittsburg Kansas 66762 Recruiting
Eye Health Vision Center South Dartmouth Massachusetts 02747 Recruiting
Northeast Eye Research Associates Woburn Massachusetts 01801 Recruiting
Oculus Research Garner North Carolina 27529 Recruiting
West Bay Eye Assoc. Warwick Rhode Island 02888 Recruiting
Zillan Clinical Research Houston Texas 77082 Recruiting
Hoopes Vision Draper Utah 84020 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07140783, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 30, 2025 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07140783 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →